“Tongxinluo preserves the renal function in diabetic kidney disease via protecting the HK-2 cells from the patterns of programmed cell death” (2021) Bangladesh Journal of Pharmacology, 16(2), pp. 52–64. doi:10.3329/bjp.v16i2.52090.